Connection

Allan Brett to Drug Approval

This is a "connection" page, showing publications Allan Brett has written about Drug Approval.
Connection Strength

0.315
  1. A Clinical Overview of Off-label Use of Gabapentinoid Drugs. JAMA Intern Med. 2019 05 01; 179(5):695-701.
    View in: PubMed
    Score: 0.167
  2. Gabapentin and Pregabalin for Pain - Is Increased Prescribing a Cause for Concern? N Engl J Med. 2017 Aug 03; 377(5):411-414.
    View in: PubMed
    Score: 0.148
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.